Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma:<i> Clinical Application to Therapeutic Drug Monitoring</i>

<div>Chemical structure of SF (a), DC (b), and IS (c).</div>

International Journal of Analytical Chemistry

fig1

Figure 1

Figure 1: Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma:<i> Clinical Application to Therapeutic Drug Monitoring</i> 

Figure 1 | Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring 